BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32606058)

  • 1. Interpretation of China's 2017 health expenditure: a latent profile analysis of panel data.
    Zang S; Zhao M; OuYang J; Wang X
    BMJ Open; 2020 Jun; 10(6):e035512. PubMed ID: 32606058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engaging sub-national governments in addressing health equities: challenges and opportunities in China's health system reform.
    Brixi H; Mu Y; Targa B; Hipgrave D
    Health Policy Plan; 2013 Dec; 28(8):809-24. PubMed ID: 23221008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equity in health financing of Guangxi after China's universal health coverage: evidence based on health expenditure comparison in rural Guangxi Zhuang autonomous region from 2009 to 2013.
    Qin X; Luo H; Feng J; Li Y; Wei B; Feng Q
    Int J Equity Health; 2017 Sep; 16(1):174. PubMed ID: 28962656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclical behaviour of public and private health expenditure in China.
    Chen G; Inder B; Lorgelly P; Hollingsworth B
    Health Econ; 2013 Sep; 22(9):1071-92. PubMed ID: 23836624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis on funds application of community based organizations involved in HIV/AIDS response and government financial investment in China, 2014].
    Zhang G; Zhu YX; Wang P; Liu P; Li JF; Sha S; Yang WZ; Li H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):232-236. PubMed ID: 28260337
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficiency of provincial government health care expenditure after China's new health care reform.
    Guo X; Zhang J; Xu Z; Cong X; Zhu Z
    PLoS One; 2021; 16(10):e0258274. PubMed ID: 34644313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional inequality in China's health care expenditures.
    Chou WL; Wang Z
    Health Econ; 2009 Jul; 18 Suppl 2():S137-46. PubMed ID: 19548323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The convergence of Chinese county government health expenditures: capitation and contribution.
    Zhang G; Zhang L; Wu S; Xia X; Lu L
    BMC Health Serv Res; 2016 Aug; 16(1):408. PubMed ID: 27538780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Primary Healthcare and Medical Expenditures in a Context of Hospital-Oriented Healthcare System in China: A National Panel Dataset, 2012-2016.
    Zhou M; Liao J; Hu N; Kuang L
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32971840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of China's health expenditure growth: based on Baumol's cost disease theory.
    Wang L; Chen Y
    Int J Equity Health; 2021 Sep; 20(1):213. PubMed ID: 34565389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with child delivery expenditure during the transition to the national implementation of the two-child policy in China.
    Zang S; OuYang J; Zhao M; Zhu Y; Liu J; Wang X
    Health Qual Life Outcomes; 2021 Jan; 19(1):30. PubMed ID: 33482815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explaining China's regional health expenditures using LM-type unit root tests.
    Chou WL
    J Health Econ; 2007 Jul; 26(4):682-98. PubMed ID: 17222930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organization and Finance of China's Health Sector: Historical Antecedents for Macroeconomic Structural Adjustment.
    Li H; Hilsenrath P
    Inquiry; 2016; 53():. PubMed ID: 26831625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional health accounts for Pakistan--expenditure disparities on provincial and district level.
    Lorenz C; Khalid M
    J Pak Med Assoc; 2011 May; 61(5):490-5. PubMed ID: 22204187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Main characteristics and historical evolution of China' s health financing transition].
    Wang Q; Fu H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):462-470. PubMed ID: 38864132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of China's National Essential Medicine Policy and Its Implications for Urban Outpatients: A Multivariate Difference-in-Differences Study.
    Ding L; Wu J
    Value Health; 2017 Mar; 20(3):412-419. PubMed ID: 28292486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of China's Zero Markup Drug Policy on provider-induced demand in secondary and tertiary hospitals.
    Zhang X; Zimmerman A; Lai H; Zhang Y; Tang Z; Tang S; Ogbuoji O
    Front Public Health; 2024; 12():1229722. PubMed ID: 38721544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of health financing patterns and the way forward in the WHO African Region.
    Kirigia JM; Preker A; Carrin G; Mwikisa C; Diarra-Nama AJ
    East Afr Med J; 2006 Sep; 83(9 Suppl):S1-28. PubMed ID: 17476860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.